Literature DB >> 952858

Ethidium bromide as a probe of conformational heterogeneity of DNA in chromatin. The role of histone H1.

J J Lawrence, M Daune.   

Abstract

The accessibility and the tertiary structure of the DNA inside chromatin were studied by using ethidium bromide (EB) as a fluorescent probe. The exclusion model of binding was refined by introductina a parameter alpha (0less than alpha less than 1) which measures the accessibility of the DNA and by taking into account when necessary the existence of two sets of binding sites. We were thus able to fit predicted and experimental isotherms and then to describe completely EB binding to native or partially histone depleted chromatin under various conditions. Itn native chromatin 95% of the DNA (alpha = 0.95) appears to be accessible to EB but two sets of sites are present. The first one corresponds to alpha = 0.13 and is characterized by an affinity constant which is higher by two orders of magnitude than that relative to pure DNA. The second set corresponds to alpha = 0.82 and the corresponding binding constant is only three or four times lower than that of pure DNA. The sites with high affinity are still present after treatment with formaldehyde but disappear after removal of histon H1. By comparison with chromatin treated with deoxycholate of with artifical complexes between H1 and DNA, high affinity sites were found only when all of the histons are bound to DNA. An alpha value around 0.8 is still obtained in 1 M NaC1 treated chromatin, pointing to the fact that histones H3 and H4 are preventing 20% of the DNA to intercalate EB.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952858     DOI: 10.1021/bi00660a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Study of propidium iodide binding to DNA in intact cells by flow cytometry.

Authors:  A Bertuzzi; I D'Agnano; A Gandolfi; A Graziano; G Starace; P Ubezio
Journal:  Cell Biophys       Date:  1990-12

2.  A rapid cytofluorometric method for quantitative DNA determination on fixed smears.

Authors:  G Mazzini; P Giordano; C M Montecucco; A Riccardi
Journal:  Histochem J       Date:  1980-03

3.  Cytochemical studies of metaphase chromosomes by flow cytometry.

Authors:  R G Langlois; A V Carrano; J W Gray; M A Van Dilla
Journal:  Chromosoma       Date:  1980       Impact factor: 4.316

4.  Ethidium bromide binding to core particle: comparison with native chromatin.

Authors:  M Erard; G C Das; G de Murcia; A Mazen; J Pouyet; M Champagne; M Daune
Journal:  Nucleic Acids Res       Date:  1979-07-25       Impact factor: 16.971

5.  Conformational state of DNA in chromatin subunits. Circular dichroism, melting, and ethidium bromide binding analysis.

Authors:  J J Lawrence; D C Chan; L H Piette
Journal:  Nucleic Acids Res       Date:  1976-11       Impact factor: 16.971

6.  Increased susceptibility of activated rat liver chromatin to DNAse I.

Authors:  I N Batova; G E Fedoseeva; A V Zelenin
Journal:  Mol Biol Rep       Date:  1979-12-31       Impact factor: 2.316

7.  The interaction of ethidium with synthetic double-stranded polynucleotides at low ionic strength.

Authors:  B C Baguley; E M Falkenhaug
Journal:  Nucleic Acids Res       Date:  1978-01       Impact factor: 16.971

8.  Effects of ethidium bromide on the production of ribosomal RNA in cultured mouse cells.

Authors:  M Lange; P May
Journal:  Nucleic Acids Res       Date:  1979-06-25       Impact factor: 16.971

9.  The strictly aerobic yeast Yarrowia lipolytica tolerates loss of a mitochondrial DNA-packaging protein.

Authors:  Jana Bakkaiova; Kosuke Arata; Miki Matsunobu; Bungo Ono; Tomoyo Aoki; Dana Lajdova; Martina Nebohacova; Jozef Nosek; Isamu Miyakawa; Lubomir Tomaska
Journal:  Eukaryot Cell       Date:  2014-06-27

10.  Selective displacement of nuclear proteins by antitumor drugs having affinity for nucleic acids.

Authors:  J Bartkowiak; J Kapuscinski; M R Melamed; Z Darzynkiewicz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.